New research highlights important insights into the long-term safety of commonly prescribed ADHD medications. A study published in JAMA Psychiatry found that methylphenidate—widely used in treatments like Ritalin and Concerta—does not increase the risk of psychosis in pediatric patients and may even offer protective benefits when used over time.
Researchers analyzed health data from nearly 4,000 children and adolescents diagnosed with ADHD and found no increased risk of psychosis among those treated with methylphenidate compared to those who were not. Notably, children under age 13 who received consistent treatment for several years showed a reduced likelihood of developing psychotic symptoms.
These findings provide reassurance for providers and families considering long-term ADHD management strategies, while reinforcing the importance of individualized treatment plans and ongoing monitoring.
Resource: ADHD medication may reduce later risk of psychosis, study finds